Scholarly Index
Jens‐Ulrich Stegmann
GlaxoSmithKline (Belgium); 944 total citations; 36 total publications; best world rank #222
GlaxoSmithKline (Belgium)
944Total citations
36Total publications
17H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 222 | BE 1 | 78.99 |
| Drug-Induced Adverse Reactions | 2021-2025 | 848 | BE 13 | 68.04 |